Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasma

MIDD

Trial design and analysis

Pharmacometrics

CNS

Yamamoto Y, Sanwald Ducray P, Björnsson MA, Smart K, Grimsey P, Vatakuti S, Portron A, Massonnet B, Norris DA, Silber Baumann HE